Latest news
- Beating Blood Cancers Blog
- Our publications
- Subscribe
- Latest news
- Social media
- Videos
- Media contacts
- Blood cancer resources
More research needed to understand Australia myeloma burden
Friday, 18 May 2018
The rate of myeloma in Australia is increasing due to an ageing population, according to the results of a new study.
Myeloma, also known as multiple myeloma, is a cancer of the plasma cells. Plasma cells are a type of white blood cell that help fight
Maddison urgently needs your help
Friday, 11 May 2018
Three-year-old Maddison woke up one morning recently in pain. Her tummy hurt—it was all swollen. When her mum, Meagan, saw it, she was worried. What could it be?
Meagan didn’t know what it was, but she knew she needed to get Maddison to a hospital. For the
Bone density treatment slows progression of leukaemia
Thursday, 10 May 2018
Researchers may have unlocked a vital key to reducing the progression of leukaemia in children, potentially prompting a change in thinking around the best way to target treatment.
In research published in the Nature journal, Leukemia, a team led by Telethon Kids Cancer Centre researcher Dr Laurence Cheung
Leukaemia Foundation nominated Dry July beneficiary
Thursday, 03 May 2018
The Leukaemia Foundation is thrilled to be a nominated beneficiary in the 2018 Dry July fundraising campaign.
Since 2008, Dry July has raised more than $30 million to support cancer services across Australia and New Zealand.
Dry July challenges you to go alcohol-free in July and ask
T-cell lymphoma medicine now accessible for all Australians
Wednesday, 28 March 2018
The Leukaemia Foundation welcomes the Federal Government’s announcement that the cancer medicine pralatrexate, sold under the name Folotyn, will be added to Pharmaceutical Benefits Scheme (PBS) from 1 April 2018.
Folotyn is used to treat patients aged 18 years or older with peripheral T-cell lymphoma (PTCL) after
Leukaemia Foundation supports myeloma biomarker breakthrough
Friday, 16 March 2018
Research released by QIMR Berghofer Medical Research Institute today identifying the IL-18 molecule as an important biomarker for myeloma is being hailed an important step by the Leukaemia Foundation.
Myeloma is a blood cancer which affects the body’s plasma cells – the cells that produce antibodies. Myeloma
Leukaemia Foundation Chairman Joins Shave Crew
Wednesday, 21 February 2018
“Be bold, go bald!”
That’s the call to action from Leukaemia Foundation Chairman, Beverley Mirolo OAM, as she prepares to lose her locks in this year’s 20th World’s Greatest Shave.
Beverley’s team is strong, with daughter Fiona, granddaughter Stephanie
Haematologist swims oceans to make a difference
Monday, 22 January 2018
Haematologist Orly Lavee will be taking on a 2km ocean swim and 10km coastal run in the Sydney Morning Herald 2018 Sun Run Cole Classic from February 3-4 to help raise awareness and funds for the Leukaemia Foundation.
One of the oldest sporting events in Australia, the
Growing concern as blood cancer rates continue to rise
Tuesday, 16 January 2018
The Leukaemia Foundation’s CEO Bill Petch is reminding the nation the number of Australians dying from blood cancer is now DOUBLE those losing their life to melanoma 1, as registrations for the 20th anniversary of World’s Greatest Shave open today.
Every day
Ibrutinib now cheaper for patients
Monday, 09 October 2017
The Leukaemia Foundation welcomes the Federal Government’s announcement that the cancer medicine, IMBRUVICA® (ibrutinib) will be added to Pharmaceutical Benefits Scheme (PBS) from 1 December 2017.
Bill Petch, CEO at the Leukaemia Foundation said this announcement is an important step forward for people living with Read More